-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QjX6O9RxPQxjczhF6z5h9FbK6GRIcYkEvgsObiHcwH/Cfud7OtD0ia5gvs3AjDhf cBxtplpKw0QFBYuJtRj2MA== 0001382333-07-000005.txt : 20070308 0001382333-07-000005.hdr.sgml : 20070308 20070308114047 ACCESSION NUMBER: 0001382333-07-000005 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070308 DATE AS OF CHANGE: 20070308 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ATHEROGENICS INC CENTRAL INDEX KEY: 0001107601 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 582108232 STATE OF INCORPORATION: GA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-60563 FILM NUMBER: 07679874 BUSINESS ADDRESS: STREET 1: 8995 WESTSIDE PARKWAY CITY: ALPHARETTA STATE: GA ZIP: 30004 BUSINESS PHONE: 6783362500 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Meditor Group Ltd CENTRAL INDEX KEY: 0001382333 IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 79 FRONT STREET CITY: HAMILTON STATE: D0 ZIP: HM11 BUSINESS PHONE: 441 296 5946 MAIL ADDRESS: STREET 1: 79 FRONT STREET CITY: HAMILTON STATE: D0 ZIP: HM11 SC 13G 1 athero13g-1.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 AtheroGenics, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 047439104 (CUSIP Number) March 02, 2007 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ]Rule 13d-1(b) [ X ]Rule 13d-1(c) [ ]Rule 13d-1(d) - ------------------------------------------------------------- CUSIP No. 047439104 1.Names of Reporting Persons. MEDITOR GROUP LTD. I.R.S. Identification Nos. of above persons (entities only). ................. 2.Check the Appropriate Box if a Member of a Group (See Instructions) [ ](a) [ ](b) 3.SEC Use Only 4.Citizenship or Place of Organization BERMUDA Number of Shares Beneficially Owned by Each Reporting Person With: 5.Sole Voting Power ......... 6.Shared Voting Power 3,839,600 7.Sole Dispositive Power ......... 8.Shared Dispositive Power 3,839,600 9.Aggregate Amount Beneficially Owned by Each Reporting Person 3,839,600 10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] 11.Percent of Class Represented by Amount in Row (9) 9.7% 12.Type of Reporting Person (See Instructions) CO - ------------------------------------------------------------- Item 1. (a) Name of Issuer AtheroGenics, Inc. (b) Address of Issuer's Principal Executive Offices 8995 Westside Parkway, Alpharetta, GA 30004 Item 2. (a) Name of Person Filing Meditor Group Ltd. (b) Address of Principal Business Office or, if none, Residence 79 Front Street, Hamilton, Bermuda (c) Citizenship Bermuda (d) Title of Class of Securities Common Stock (e) CUSIP Number 047439104 Item 3. Not applicable. Item 4. Ownership. (a) Amount beneficially owned: 3,839,600 (b) Percent of class: 9.7% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote ......... (ii) Shared power to vote or to direct the vote 3,839,600 (iii) Sole power to dispose or to direct the disposition of ......... (iv) Shared power to dispose or to direct the disposition of 3,839,600 Item 5. Ownership of Five Percent or Less of a Class Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Various persons, as investment management clients of Meditor Group Ltd., have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, these securities. To the knowledge of Meditor Group Ltd., no one such person's interest in the common stock of the Issuer is more than 5%. Meditor Group Ltd. became the beneficial owner of more than 5% of the common stock of the Issuer on behalf of such persons on January 05, 2007. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person. Not applicable. Item 8. Identification and Classification of Members of the Group Not applicable. Item 9. Notice of Dissolution of Group Not applicable. Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. March 8, 2007 Andrew Black A. Black (Director) -----END PRIVACY-ENHANCED MESSAGE-----